Skip to main content
Screener/Healthcare/Biotechnology

FDMT — 4D Molecular Therapeutics, Inc.

NASDAQ
$11.75+1.34 (+12.91%)
Small CapUnder $20Healthcare
$3.68
$12.34
$10.22
$12.18
EPS (TTM)$-2.66
P/E Ratio-3.89
Dividend Yield—
Market Cap$461.6M
Volume1.55M
Prev Close$10.42
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$68.8M$-1.01——
Q4 '25$85.1M$19.4M$0.3497.7%22.8%
Q3 '25$90K-$56.9M$-1.01-52386.7%-63195.6%
Q2 '25$15K-$54.7M$-0.98-319573.3%-364386.7%
Q1 '25$14K-$48.0M$-0.86100.0%-342657.1%
Q4 '24$1K-$49.7M$-0.90-178300.0%-4967100.0%
Q3 '24$3K-$43.8M$-0.79100.0%-1461433.3%
Q2 '24$5K-$35.0M$-0.63-637100.0%-699060.0%
Get Your Daily Market Recap